Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance

Active surveillance (AS) is currently a widely accepted treatment option for men with clinically localized prostate cancer (PCa). Several reports have highlighted the association of low serum testosterone levels with high-grade, high-stage PCa. However, the impact of serum testosterone as a predicto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferro, Matteo, Lucarelli, Giuseppe, Bruzzese, Dario, Lorenzo, Giuseppe Di, Perdonà, Sisto, Autorino, Riccardo, Cantiello, Francesco, Rocca, Roberto La, Busetto, Gian Maria, Cimmino, Amelia, Buonerba, Carlo, Battaglia, Michele, Damiano, Rocco, Cobelli, Ottavio De, Mirone, Vincenzo, Terracciano, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392340/
https://www.ncbi.nlm.nih.gov/pubmed/27793023
http://dx.doi.org/10.18632/oncotarget.12906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392340/
https://www.ncbi.nlm.nih.gov/pubmed/27793023
http://dx.doi.org/10.18632/oncotarget.12906

Ejemplares similares